Sanchez Ramiro — SEC insider filings

SEC reporting owner CIK 1830326. 17 insider filings on record with FilingPulse; latest filed 2026-10-23.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-10-30 to 2026-10-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cerevel Therapeutics Holdings, Inc. (CERE)Chief Medical Officer10—4 legs · 37,652 sh · $1,569,32117
Rapport Therapeutics, Inc. (RAPP)Director41 leg · 3,600 sh · $98,478—3
Alto Neuroscience, Inc. (ANRO)Director3——4

Insider filings — Sanchez Ramiro

FiledFormIssuerReported transactionsSource
2026-10-234Rapport Therapeutics, Inc. (RAPP)Purchase (P): 3,600 @ $27.35EDGAR
2026-06-104Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 15,200 (derivative) @ $0EDGAR
2026-05-144Alto Neuroscience, Inc. (ANRO)Grant/award (A): 10,958 (derivative) @ $0EDGAR
2026-01-064Alto Neuroscience, Inc. (ANRO)Grant/award (A): 3,806 (derivative) @ $11.82EDGAR
2025-08-144Alto Neuroscience, Inc. (ANRO)Grant/award (A): 30,574 (derivative) @ $0 · Grant/award (A): 3,928 (derivative) @ $2.21EDGAR
2025-06-184Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 10,925 (derivative) @ $0EDGAR
2024-11-074Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 29,756 (derivative) @ $0EDGAR
2024-08-054Cerevel Therapeutics Holdings, Inc. (CERE)Disposition to issuer (D): 14,673 · Disposition to issuer (D): 1,393,153 (derivative) · Disposition to issuer (D): 87,573 (derivative) @ $0EDGAR
2024-01-234Cerevel Therapeutics Holdings, Inc. (CERE)Grant/award (A): 87,573 (derivative) @ $0EDGAR
2023-12-284Cerevel Therapeutics Holdings, Inc. (CERE)Option exercise (M): 10,000 @ $3.50 · Sale (S): 10,000 @ $42.47 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-12-214Cerevel Therapeutics Holdings, Inc. (CERE)Option exercise (M): 24,825 · Sale (S): 10,152 @ $41.42 · Option exercise (M): 24,825 (derivative) @ $0EDGAR
2023-12-194Cerevel Therapeutics Holdings, Inc. (CERE)Option exercise (M): 7,500 @ $9.88 · Sale (S): 7,500 @ $41.39 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2023-12-114Cerevel Therapeutics Holdings, Inc. (CERE)Option exercise (M): 10,000 @ $3.50 · Sale (S): 10,000 @ $41.37 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-02-084Cerevel Therapeutics Holdings, Inc. (CERE)Grant/award (A): 97,691 (derivative) @ $0 · Grant/award (A): 24,825 (derivative) @ $0EDGAR
2022-02-114Cerevel Therapeutics Holdings, Inc. (CERE)Grant/award (A): 168,856 (derivative) @ $0EDGAR
2021-02-054Cerevel Therapeutics Holdings, Inc. (CERE)Grant/award (A): 278,637 (derivative) @ $0EDGAR
2020-10-304Cerevel Therapeutics Holdings, Inc. (CERE)Grant/award (A): 130,890 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1830326 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs